Cargando…

Rapidly Evolving Treatment Landscape for Metastatic Esophagogastric Carcinoma: Review of Recent Data

Esophagogastric cancer (EGC) is a heterogeneous group of malignancies that collectively represent the 2nd leading cause of cancer deaths worldwide. While surgery in combination with chemotherapy and/or radiation therapy represents the primary curative treatment for early stage disease, survival outc...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kankeu Fonkoua, Lionel Aurelien, Yoon, Harry H
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove 2021
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8352646/ https://www.ncbi.nlm.nih.gov/pubmed/34385820 http://dx.doi.org/10.2147/OTT.S216047

Ejemplares similares

Molecular Characterization of Gastric Carcinoma: Therapeutic Implications for Biomarkers and Targets
por: Kankeu Fonkoua, Lionel, et al.
Publicado: (2018)

Research Progress of Biliary Tract Cancers
por: Fonkoua, Lionel Aurelien A. Kankeu, et al.
Publicado: (2021)

The Evolving Landscape of Cytoreductive Nephrectomy in Metastatic Renal Cell Carcinoma
por: Studentova, Hana, et al.
Publicado: (2023)

The Evolving Treatment Landscape for Metastatic Differentiated Thyroid Cancer
por: Grande, Carolyn, et al.
Publicado: (2014)

The rapidly evolving treatment landscape of advanced prostate, bladder, and renal cell carcinomas
por: Hahn, Andrew W., et al.
Publicado: (2020)

CAR T cell therapy and the tumor microenvironment: Current challenges and opportunities
por: Kankeu Fonkoua, Lionel A., et al.
Publicado: (2022)

The Evolving Biomarker Landscape for Treatment Selection in Metastatic Colorectal Cancer
por: Taieb, Julien, et al.
Publicado: (2019)

A rapidly evolving landscape: immune checkpoint inhibitors in pretreated metastatic endometrial cancer
por: Tinker, Anna V., et al.
Publicado: (2023)

Immune Checkpoint Inhibitors: Changing the Treatment Landscape in Esophagogastric Adenocarcinoma
por: Lynch, Emer, et al.
Publicado: (2023)

The Rapidly Evolving Landscape of First‐Line Targeted Therapy in Metastatic Urothelial Cancer: A Systematic Review
por: Lavoie, Jean‐Michel, et al.
Publicado: (2021)

Targeted Therapies for Metastatic Esophagogastric Cancer
por: Reddy, Deepa, et al.
Publicado: (2011)

Navigating the Rapidly Evolving Advanced Urothelial Carcinoma Treatment Landscape: Insights from Italian Experts
por: Santini, Daniele, et al.
Publicado: (2023)

Rapidly Evolving Landscape and Future Horizons in Hepatocellular Carcinoma in the Era of Immuno-Oncology
por: Kang, Sandra Mirie, et al.
Publicado: (2022)

The Advanced Practitioner's Role in the Rapidly Evolving Landscape of Precision Medicine
por: Moore, Donald C., et al.
Publicado: (2023)

A population-based comparison of patients with metastatic esophagogastric carcinoma between Japan and the Netherlands
por: Pape, Marieke, et al.
Publicado: (2023)

Interventional Protocol for Treatment of Complications after Esophagojejunostomy for Esophagogastric Carcinoma
por: Bi, Yonghua, et al.
Publicado: (2019)

HCV Council – critical appraisal of data: recommendations for clinical practice in a rapidly evolving therapeutic landscape
por: Reau, Nancy, et al.
Publicado: (2015)

Metastatic Urothelial Cancer: a rapidly changing treatment landscape
por: Stecca, Carlos, et al.
Publicado: (2021)

Recent advances in multidisciplinary therapy for adenocarcinoma of the esophagus and esophagogastric junction
por: Zheng, Yi-Han, et al.
Publicado: (2022)

Metastatic Hormone-sensitive Prostate Cancer: Current Perspective on the Evolving Therapeutic Landscape
por: Hall, Mary E, et al.
Publicado: (2020)

The Evolving Landscape of Antibody–Drug Conjugates: In Depth Analysis of Recent Research Progress
por: Sasso, Janet M., et al.
Publicado: (2023)

The Evolving Landscape of the Economics of HIV Treatment and Prevention
por: Nosyk, Bohdan, et al.
Publicado: (2012)

Gastric cancer: current and evolving treatment landscape
por: Sun, Weijing, et al.
Publicado: (2016)

The evolving landscape of immunotherapy for the treatment of allergic conditions
por: Pandya, Aarti, et al.
Publicado: (2023)

Evolving Pharmacotherapies for the Treatment of Metastatic Melanoma
por: Salama, April K.S.
Publicado: (2013)

Hidden genomic evolution in a morphospecies—The landscape of rapidly evolving genes in Tetrahymena
por: Xiong, Jie, et al.
Publicado: (2019)

Rapidly evolving treatment paradigm and considerations for sequencing therapies in metastatic prostate cancer—a narrative review
por: Sagaram, Smitha, et al.
Publicado: (2021)

Urothelial carcinoma: the evolving landscape of immunotherapy for patients with advanced disease
por: Dietrich, Brian, et al.
Publicado: (2018)

The Evolving Landscape of Immunotherapy-Based Combinations for Frontline Treatment of Advanced Renal Cell Carcinoma
por: Amin, Asim, et al.
Publicado: (2019)

Challenges in the Evolving CME Landscape
por: Gillgrass, Darren
Publicado: (2020)

Cervical screening: the evolving landscape
por: Davies-Oliveira, Jennifer C, et al.
Publicado: (2022)

Evolving treatment landscape for early and advanced pancreatic cancer
por: Lau, Sally C, et al.
Publicado: (2017)

The Evolving Pharmacotherapeutic Landscape for the Treatment of Sickle Cell Disease
por: Ballas, Samir K.
Publicado: (2020)

Chronic thromboembolic pulmonary hypertension: the evolving treatment landscape
por: Kim, Nick H., et al.
Publicado: (2015)

Molecular classification of esophagogastric junction carcinoma correlated with prognosis
por: Zou, Long, et al.
Publicado: (2017)

The impact of esophagogastric varices on the prognosis of patients with hepatocellular carcinoma
por: Hsieh, Wei-Yao, et al.
Publicado: (2017)

A case report of adenosquamous carcinoma of the esophagogastric junction
por: Fukai, Harunari, et al.
Publicado: (2022)

Phase I study of everolimus and mitomycin C for patients with metastatic esophagogastric adenocarcinoma
por: Werner, Dominique, et al.
Publicado: (2013)

A population-based study in synchronous versus metachronous metastatic esophagogastric adenocarcinoma
por: Pape, Marieke, et al.
Publicado: (2022)

The Evolving Treatment Landscape of Advanced Renal Cell Carcinoma in Patients Progressing after VEGF Inhibition
por: Barata, Pedro C., et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_o9o6bqteh02mvtqhqg2p7ggakl